Business Description
Ardent Health Partners Inc
NAICS : 621420
SIC : 8062
ISIN : US03980N1072
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.25 | |||||
Equity-to-Asset | 0.21 | |||||
Debt-to-Equity | 2.24 | |||||
Debt-to-EBITDA | 5.64 | |||||
Interest Coverage | 4.31 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 2.04 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 9.9 | |||||
3-Year EBITDA Growth Rate | 12.5 | |||||
3-Year Book Growth Rate | 21 | |||||
Future 3-5Y EPS without NRI Growth Rate | 72.18 | |||||
Future 3-5Y Total Revenue Growth Rate | 7.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.21 | |||||
9-Day RSI | 39.76 | |||||
14-Day RSI | 41.44 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.91 | |||||
Quick Ratio | 1.78 | |||||
Cash Ratio | 0.63 | |||||
Days Sales Outstanding | 46.78 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | 4.44 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | 4.48 | |||||
Net Margin % | 1.55 | |||||
FCF Margin % | 1.74 | |||||
ROE % | 10.63 | |||||
ROA % | 1.88 | |||||
ROIC % | 6.27 | |||||
ROC (Joel Greenblatt) % | 11.21 | |||||
ROCE % | 6.71 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 25.63 | |||||
Forward PE Ratio | 8.77 | |||||
PE Ratio without NRI | 24.43 | |||||
Price-to-Owner-Earnings | 74.37 | |||||
PEG Ratio | 0.99 | |||||
PS Ratio | 0.4 | |||||
PB Ratio | 2.29 | |||||
Price-to-Tangible-Book | 29.52 | |||||
Price-to-Free-Cash-Flow | 22.68 | |||||
Price-to-Operating-Cash-Flow | 8.59 | |||||
EV-to-EBIT | 15.68 | |||||
EV-to-Forward-EBIT | 8.11 | |||||
EV-to-EBITDA | 10.01 | |||||
EV-to-Forward-EBITDA | 5.06 | |||||
EV-to-Revenue | 0.7 | |||||
EV-to-Forward-Revenue | 0.63 | |||||
EV-to-FCF | 40.24 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.75 | |||||
Price-to-Graham-Number | 5.63 | |||||
Earnings Yield (Greenblatt) % | 6.38 | |||||
FCF Yield % | 4.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:ARDT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Ardent Health Partners Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 5,705.817 | ||
EPS (TTM) ($) | 0.63 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 41.44 | ||
14-Day ATR ($) | 0.87894 | ||
20-Day SMA ($) | 16.85 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 14.575 - 20.72 | ||
Shares Outstanding (Mil) | 142.73 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ardent Health Partners Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ardent Health Partners Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Ardent Health Partners Inc Frequently Asked Questions
What is Ardent Health Partners Inc(ARDT)'s stock price today?
When is next earnings date of Ardent Health Partners Inc(ARDT)?
Does Ardent Health Partners Inc(ARDT) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |